Procter & Gamble Health Ltd

BSE: 500126

12

total announcements

500126.BO · 15 min delayed

BSECompany Update6d ago

Procter & Gamble Health Ltd

Stock Exchange is informed about an update on Ease of doing Investment - Special Window for Transfer and Dematerialization.

Procter & Gamble Health Ltd has informed the stock exchange about an update on Ease of doing Investment - Special Window for Transfer and Dematerialization. SEBI has extended the timeline for re-lodging transfer requests for physical shares lodged prior to April 01, 2019, and rejected/returned/not attended to due to deficiency in documents/process.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change4 Sept 2026

Procter & Gamble Health Ltd

The shareholders at their AGM held on September 3, 2026 approved the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of 5 years effective November 15, 2026.

Procter & Gamble Health Ltd has announced the re-appointment of Mr. S. Madhavan as Independent Director for a period of 5 years, effective November 15, 2026, following approval by shareholders at the 59th Annual General Meeting on September 3, 2026.

Read more →📎 1 attachment
BSEAGM/EGMResults4 Sept 2026

Procter & Gamble Health Ltd

Scrutinizers Report and E-Voting results for the Annual General Meeting held on September 3, 2026.

Procter & Gamble Health Ltd has announced the results of its 59th Annual General Meeting (AGM), which was held on September 3, 2026. The meeting saw a total of 5 resolutions being passed, including the appointment of a new director, ratification of remuneration payable to the Cost Auditor, and confirmation of payment of interim dividend and declaration of Final Dividend for the Financial Year ended March 31, 2026.

Read more →📎 1 attachment
BSEAGM/EGMResults3 Sept 2026

Procter & Gamble Health Ltd

Enclosed a summary of proceedings of the Annual General Meeting held today, viz., September 3, 2026.

Procter & Gamble Health Ltd held its 59th Annual General Meeting on September 3, 2026, through video conference. The meeting approved the audited balance sheet, statement of profit and loss, and auditors' reports. The company also declared interim and final dividends, appointed a new director, and ratified the remuneration of the cost auditor. The meeting concluded with the announcement of the voting results to be made available on the company's website within 2 working days.

Read more →📎 1 attachment
BSEAGM/EGMResults12 Aug 2026

Procter & Gamble Health Ltd

Enclosed herewith is the Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company, scheduled on Thursday, September 3, 2026 at 2:30 p.m.

Procter & Gamble Health Ltd has announced its Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company, scheduled on September 3, 2026. The report includes financial highlights, director's report, business responsibility & sustainability report, and corporate governance report. Shareholders can register to express their views or ask questions during the AGM by August 27, 2026.

Read more →📎 1 attachment
BSECorp. ActionDividend10 Aug 2026

Procter & Gamble Health Ltd

Record Date for Purpose of Dividend

Procter & Gamble Health Ltd has announced the record date for the purpose of dividend and AGM, with the 59th AGM scheduled for September 3, 2026, and the record date set for August 27, 2026. The company also notified the payment of final dividend to eligible members by September 27, 2026.

Read more →📎 1 attachment
BSEResult▲ PositiveResults6 Aug 2026

Procter & Gamble Health Ltd

Unaudited Financial Results for the Quarter ended June 30, 2026

Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of ₹12,912 lakhs, a 9.3% increase from the previous quarter's ₹11,811 lakhs. The company's total income was ₹37,459 lakhs, a 0.4% increase from the previous quarter's ₹37,045 lakhs. Expenses for the quarter were ₹27,027 lakhs, a 12.1% decrease from the previous quarter's ₹30,727 lakhs.

Read more →📎 1 attachment
BSEBoard MeetingResults6 Aug 2026

Procter & Gamble Health Ltd

Outcome of Board Meeting.

Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹3,637.7 lakhs, total income at ₹36,759 lakhs, and profit before tax at ₹12,912 lakhs.

Read more →📎 1 attachment